Virtu Financial’s Acceleron Pharma XLRN Stock Holding History

Virtu Financial’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,355	Closed	-$577K	–	2448
2021 Q3	$577K	Buy	+3,355	New	+$439K	0.05%	397
2020 Q3	–	Sell	-14,462	Closed	-$1.38M	–	1737
2020 Q2	$1.38M	Buy	+14,462	New	+$1.39M	0.16%	130
2017 Q4	–	Sell	-9,144	Closed	-$341K	–	3230
2017 Q3	$341K	Buy	+9,144	New	+$317K	0.02%	1264

Virtu Financial's XLRN Position: Q4 2021 in Review

Virtu Financial sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 3,355 shares — an estimated $577K sold.

Virtu Financial first reported a position in XLRN in Q3 2017 and held it in 3 quarters. The position peaked at $1.38M in Q2 2020. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Virtu Financial reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Virtu Financial sold 3,355 Acceleron Pharma shares in Q4 2021, an estimated $577K.
Virtu Financial first reported a position in Acceleron Pharma in Q3 2017 and held it in 3 quarters.
Virtu Financial's Acceleron Pharma position peaked at $1.38M in Q2 2020.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Virtu Financial's 13F filing for Q4 2021, filed 17 Feb 2022.